Rafferty Asset Management’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
BG
AC
FLSM
WA
RCM
Rafferty Asset Management's MGNX Position: Q2 2024 in Review
Rafferty Asset Management sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 352,695 shares — an estimated $5.19M sold.
Rafferty Asset Management first reported a position in MGNX in Q1 2019 and held it in 14 quarters. The position peaked at $5.19M in Q1 2024. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.
- Rafferty Asset Management reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
- Rafferty Asset Management sold 352,695 MacroGenics shares in Q2 2024, an estimated $5.19M.
- Rafferty Asset Management first reported a position in MacroGenics in Q1 2019 and held it in 14 quarters.
- Rafferty Asset Management's MacroGenics position peaked at $5.19M in Q1 2024.
- 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.
Based on Rafferty Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.